TB500 (10mg)

TB-500 is a synthetic peptide derived from thymosin beta-4 that promotes tissue repair, wound healing, and cell migration.

TB-500 is a lab-synthesized fragment of thymosin beta-4 (Tβ4), a naturally occurring peptide found in nearly all human and animal cells, particularly in platelets, wound fluid, and areas of active tissue repair. The peptide consists of a heptapeptide sequence (Ac-LKKTETQ), which represents the active actin-binding region of Tβ4 responsible for its regenerative properties. Unlike the full 43-amino-acid Tβ4, TB-500 is smaller, enhancing its bioavailability and making it more practical for research and therapeutic use.

Mechanism of Action
TB-500 works primarily by binding to actin, a protein essential for cell structure and movement. This binding promotes cell migration to injury sites, accelerates wound healing, and facilitates tissue regeneration. It also upregulates cell-binding proteins, encourages angiogenesis (formation of new blood vessels), and modulates inflammation to support efficient tissue repair. These effects make TB-500 particularly useful for muscle, tendon, ligament, and joint recovery.

Potential Benefits
Injury Recovery: Enhances healing of tendons, ligaments, muscles, and skin wounds.
Anti-inflammatory Effects: Reduces chronic inflammation at injury sites.
Improved Mobility and Endurance: Supports tissue repair and functional recovery.
Cardiovascular and Eye Health: Preclinical studies suggest benefits in heart function and corneal wound healing

Research and Safety
Most TB-500 research is preclinical, conducted in animal models, and no completed human clinical trials exist specifically for TB-500. While studies show promising results in tissue repair and regeneration, its long-term safety and efficacy in humans remain unproven. TB-500 is banned in competitive sports by organizations like WADA due to its performance-enhancing potential. Use should be approached with caution and under expert guidance.

Summary
TB-500 is a synthetic, active fragment of thymosin beta-4 that enhances the body’s natural healing processes by promoting cell migration, angiogenesis, and tissue repair. While it shows significant promise in preclinical studies for injury recovery and regenerative medicine, its use in humans is experimental, and it is not approved for general therapeutic use.